Novo Nordisk, a leading global healthcare company, announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment marks the ...
Danish pharma giant Novo Nordisk (NVO) will make a significant investment of approximately $1.2 billion to construct a new production facility in Odense, Denmark. The new facility will focus on ...
Novo Nordisk (Copenhagen: NOVOB), the market leader in diabetes treatments, is a good example of this type of stock. Diabetes is the world’s fastest-growing major disease. There were 108 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback